0001437749-24-011423.txt : 20240408 0001437749-24-011423.hdr.sgml : 20240408 20240408171427 ACCESSION NUMBER: 0001437749-24-011423 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240408 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240408 DATE AS OF CHANGE: 20240408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474671997 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 24830441 BUSINESS ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 5300 MEMORIAL DRIVE STREET 2: SUITE 950 CITY: HOUSTON STATE: TX ZIP: 77007 8-K 1 mbrx20240404_8k.htm FORM 8-K mbrx20240404_8k.htm
false 0001659617 0001659617 2024-04-08 2024-04-08
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): April 8, 2024
 
mbrx20240404_8kimg001.jpg
 
 
 
MOLECULIN BIOTECH, INC.
(Exact Name of Registrant as Specified in its Charter)
 
Delaware
001-37758
47-4671997
(State or Other Jurisdiction of
Incorporation or Organization)
(Commission File No.)
(I.R.S. Employer Identification
No.)
 
5300 Memorial Drive, Suite 950, Houston, TX 77007
(Address of principal executive offices and zip code)
 
(713) 300-5160
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed from last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).          Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol (s)
Name of each exchange on which registered
Common Stock, par value $.001 per share
MBRX
The NASDAQ Stock Market LLC
 
 
 
 
Item 8.01
Other Events
 
As previously reported, on May 5, 2023, Moleculin Biotech, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”).
 
On April 8, 2024, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with Bid Price Rule 5550(a)(2) as a result of the closing bid price of the Company’s common stock being at $1.00 per share or greater for the 10 consecutive business days from March 22, 2024 through April 5, 2024.
 
Accordingly, the Company is in compliance with the Bid Price Rule and Nasdaq considers the matter closed.
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MOLECULIN BIOTECH, INC. 
  
       
       
 
Date:
April 8, 2024
  
       
 
By:
/s/ Jonathan P. Foster
  
   
Jonathan P. Foster
  
 
 
 
 
 EX-101.SCH 2 mbrx-20240408.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 3 mbrx-20240408_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 mbrx-20240408_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Title of 12(b) Security Trading Symbol Security Exchange Name Amendment Flag Entity, Central Index Key EX-101.PRE 5 mbrx-20240408_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 mbrx20240404_8kimg001.jpg begin 644 mbrx20240404_8kimg001.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document And Entity Information
Apr. 08, 2024
Document Information [Line Items]  
Entity, Registrant Name MOLECULIN BIOTECH, INC.
Document, Type 8-K
Document, Period End Date Apr. 08, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-37758
Entity, Tax Identification Number 47-4671997
Entity, Address, Address Line One 5300 Memorial Drive, Suite 950
Entity, Address, City or Town Houston
Entity, Address, State or Province TX
Entity, Address, Postal Zip Code 77007
City Area Code 713
Local Phone Number 300-5160
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Title of 12(b) Security Common Stock
Trading Symbol MBRX
Security Exchange Name NASDAQ
Amendment Flag false
Entity, Central Index Key 0001659617
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.mbrx.com/20240408/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports mbrx-20240408.xsd mbrx-20240408_def.xml mbrx-20240408_lab.xml mbrx-20240408_pre.xml mbrx20240404_8k.htm mbrx20240404_8kimg001.jpg http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mbrx20240404_8k.htm": { "nsprefix": "mbrx", "nsuri": "http://www.mbrx.com/20240408", "dts": { "schema": { "local": [ "mbrx-20240408.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "mbrx-20240408_def.xml" ] }, "labelLink": { "local": [ "mbrx-20240408_lab.xml" ] }, "presentationLink": { "local": [ "mbrx-20240408_pre.xml" ] }, "inline": { "local": [ "mbrx20240404_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.mbrx.com/20240408/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mbrx20240404_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mbrx20240404_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.mbrx.com/20240408/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001437749-24-011423-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-011423-xbrl.zip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end XML 18 mbrx20240404_8k_htm.xml IDEA: XBRL DOCUMENT 0001659617 2024-04-08 2024-04-08 false 0001659617 8-K 2024-04-08 MOLECULIN BIOTECH, INC. DE 001-37758 47-4671997 5300 Memorial Drive, Suite 950 Houston TX 77007 713 300-5160 false false false false false Common Stock MBRX NASDAQ